A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

Indore: MGM Medical College on Saturday announced its successful treatment of a blood cancer patient using CAR T-cell therapy ...

Cancer patients given experimental treatment that programmes the body to attack rogue cells live 40 per cent longer, major research shows.

A LIVING cancer drug has been proven to work against solid tumours for the first time. Immune-boosting CAR-T therapy removes ...

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

During a live event, Konstantinos Sdrimas, MD, asked participants what community oncologists should consider when referring ...

CAR T cell immunotherapy, which uses a patient's own modified immune cells to find and destroy cancer cells, can produce ...

Overcoming current limitations and expanding the reach of CAR-T therapeutics could unlock promising new treatment ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

As community oncology evolves to deliver chimeric antigen receptor (CAR) T and bispecific therapies closer to home, support ...

Researchers are developing an in vivo approach to engineer cancer-fighting immune cells, potentially making the powerful CAR ...

The US Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to AbelZeta ...